Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases

Details for Australian Patent Application No. 2006202316 (hide)

Owner Celgene Corporation

Inventors Zeldis, Jerome B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006202316

Parent 2003234626

Filing date 31 May 2006

Wipo publication date 22 June 2006

Acceptance publication date 10 April 2008

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/00 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/425 (2006.01) - Thiazoles

A61K 31/454 (2006.01)

A61K 31/515 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

15 June 2006 Complete Application Filed

22 June 2006 Application Open to Public Inspection

  Published as AU-B-2006202316

10 April 2008 Application Accepted

  Published as AU-B-2006202316

7 August 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006202317-Discovery of therapeutic products

2006202315-Covert security coating